Landscapes / Companies
Beijing VDJBio Co., LTD. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Next date
Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody, Phase 3 trial completes
Drugs
2
in active trials · 4 in all
Trials
4 active
7 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | 9 Jun 2027Phase 3 trial completes | |||
| Next date | 9 Jun 2027 · Phase 3 trial completes | ||||
| Also tested for | Anti IL-6R, Idiopathic Multicentric Castleman's Disease and 2 more | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Nov 2028Phase 1 trial completes | |||
| Next date | 30 Nov 2028 · Phase 1 trial completes | ||||
| Also tested for | Ulcerative Colitis (UC) | ||||
| Open drug page | |||||
About
- No active trial
- IL-6R Monoclonal Antibody, Recombinant human CTLA-4-FC fusion protein
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021